India's pharmaceutical industry could take a revenue hit of 4-5% because of price cuts resulting from the new drug price control order, or DPCO, notified on Thursday, analysts say.The Drugs (Price Control) Order, 2013, which replaced the DPCO of 1995, ...
[Published Individual.com - 2 hours ago]